Patent 7115408 was granted and assigned to ISTA Pharmaceuticals on October, 2006 by the United States Patent and Trademark Office.
This invention relates generally to the use of annexin II for the purpose of stabilizing a hyaluronidase enzyme for administration to the eyes of humans or other mammals.